Skip to content

Ayurvedic treatment of Oral Submucous Fibrosis (Unable to open mouth) with Madhupippalyadi Yoga Pratisarana (local application over gums lepa ),Nishadi Taila Kavala (garggle) with and without Rasayana Yoga (internally oral medicine)

Role of Madhupippalyadi Yoga Pratisarana, Nishadi Taila Kavala with and without Rasayana Yoga Orally in the management of Oral Submucous Fibrosis - An Open Labelled Randomized Comparative Clinical Trial

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084806
Enrollment
30
Registered
2025-04-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: O- Medical and Surgical

Interventions

None listed

Sponsors

Institute of Teaching and Research in Ayurveda, Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age Group between 18- 60 year old 2.The patient having cinical signs and symptoms blanching and stiffness of oral mucosa , altered taste sensation,altered salivation, repeated vesicular eruption and ulceration on buccal mucosa , palate and pillars , burning sensation in mouth , intolerance to hot and spicy foods, difficulty in opening mouth 3.Interincisal distance of more than 15mm 4.Patient Having minimum two Clinical symptoms of Oral Submucous Fibrosis will be included 4.Primary symptom is Blanching and stiffness of oral mucosa along with any other symptoms of osmf

Exclusion criteria

Exclusion criteria: 1.Age less than 18-60 years 2.Extensive Fibrosis of oral mucosa severe trismus with an interincisal distance of less than 15mm 3.Disease most advanced with premalignant and malignant changes. 4.Oral manifestation of scleroderma. 5.Oral lichen planus. 6.Chronic debilitating conditions like DM, HTN. 7.Patients not willing to give up habits of gutkha, pan masala, mawa, tobacco, betel quid or betel nut chewing. 8.Pregnant women should be excluded. 9.The patients taking any other systemic drugs which can alter the result of study.

Design outcomes

Primary

MeasureTime frame
Efficacy of intervention on signs and symptoms of Oral Submucous Fibrosis (OSMF).Timepoint: during the treatment period at baseline 8 Weeks

Secondary

MeasureTime frame
Improvement in the quality of life of the patient Assessment of recurrence of signs & symptoms of Oral Submucous Fibrosis (OSMF) during follow up periodTimepoint: During follow up period on 15th ,30th,45th & 60th day

Countries

India

Contacts

Public ContactProf Dr D B Vaghela

ITRA Jamnagar

drvaghela@rediffmail.com9825407899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026